Evergreen Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
11,231
+1,696
+18% +$148K 0.02% 525
2026
Q1
$813K Buy
9,535
+4,854
+104% +$433K 0.02% 559
2025
Q4
$370K Sell
4,681
-225
-5% -$17.6K 0.01% 917
2025
Q3
$392K Buy
4,906
+337
+7% +$28.7K 0.01% 783
2025
Q2
$415K Buy
4,569
+171
+4% +$15.6K 0.01% 645
2025
Q1
$412K Buy
4,398
+1,903
+76% +$170K 0.01% 584
2024
Q4
$227K Sell
2,495
-487
-16% -$46.5K 0.01% 902
2024
Q3
$310K Sell
2,982
-508
-15% -$51.8K 0.01% 696
2024
Q2
$339K Buy
3,490
+141
+4% +$13K 0.01% 615
2024
Q1
$302K Sell
3,349
-203
-6% -$17.2K 0.01% 629
2023
Q4
$283K Sell
3,552
-1,386
-28% -$104K 0.01% 617
2023
Q3
$351K Sell
4,938
-457
-8% -$34.2K 0.02% 503
2023
Q2
$416K Sell
5,395
-71
-1% -$5.5K 0.02% 440
2023
Q1
$411K Buy
5,466
+1,212
+28% +$90.1K 0.02% 418
2022
Q4
$335K Buy
4,254
+798
+23% +$59.8K 0.02% 452
2022
Q3
$242K Buy
3,456
+606
+21% +$47.5K 0.01% 500
2022
Q2
$228K Sell
2,850
-3,859
-58% -$302K 0.01% 492
2022
Q1
$509K Buy
6,709
+315
+5% +$25K 0.02% 374
2021
Q4
$546K Buy
6,394
+1,762
+38% +$138K 0.02% 361
2021
Q3
$350K Buy
4,632
+1,712
+59% +$136K 0.02% 406
2021
Q2
$238K Buy
2,920
+158
+6% +$12.9K 0.01% 465
2021
Q1
$218K Sell
2,762
-967
-26% -$75.8K 0.01% 462
2020
Q4
$319K Buy
3,729
+22
+0.6% +$1.82K 0.02% 336
2020
Q3
$286K Buy
3,707
+112
+3% +$8.54K 0.02% 335
2020
Q2
$263K Sell
3,595
-180
-5% -$12.8K 0.02% 328
2020
Q1
$251K Buy
3,775
+186
+5% +$13.1K 0.02% 300
2019
Q4
$247K Buy
+3,589
New +$245K 0.02% 383
2019
Q3
Sell
-2,787
Closed -$200K 431
2019
Q2
$200K Buy
+2,787
New +$198K 0.02% 395
2018
Q2
Sell
-3,153
Closed -$226K 373
2018
Q1
$226K Buy
+3,153
New +$227K 0.02% 313

Other funds holding CL

Evergreen Capital Management's CL Position: Q2 2026 in Review

Evergreen Capital Management increased its Colgate-Palmolive (CL) stake by 18% in Q2 2026, buying an estimated $148K and bringing the position to 11,231 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #525.

Evergreen Capital Management first reported a position in CL in Q1 2018 and has held it in 29 quarters since. 600 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Evergreen Capital Management held 11,231 shares of Colgate-Palmolive worth $1.03M as of Q2 2026.
  • Evergreen Capital Management bought 1,696 Colgate-Palmolive shares in Q2 2026, an estimated $148K.
  • Colgate-Palmolive made up 0.02% of Evergreen Capital Management's portfolio in Q2 2026, its #525 holding.
  • Evergreen Capital Management first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 29 quarters since.
  • 600 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.